SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014278
Filing Date
2020-07-31
Accepted
2020-07-31 08:56:18
Documents
78
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1414217
7 ex31-1.htm EX-31.1 16320
8 ex31-2.htm EX-31.2 16440
9 ex32-1.htm EX-32.1 5570
10 ex32-2.htm EX-32.2 5792
  Complete submission text file 0001493152-20-014278.txt   6165114

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vbic-20200630.xsd EX-101.SCH 53906
3 XBRL CALCULATION FILE vbic-20200630_cal.xml EX-101.CAL 65710
4 XBRL DEFINITION FILE vbic-20200630_def.xml EX-101.DEF 193716
5 XBRL LABEL FILE vbic-20200630_lab.xml EX-101.LAB 391002
6 XBRL PRESENTATION FILE vbic-20200630_pre.xml EX-101.PRE 308709
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 965350
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 201063835
SIC: 2834 Pharmaceutical Preparations